Key Drivers
- Quarterly Improvement
- Weak Liquidity
- High Leverage
AIAI Summary
FTRE is a leveraged turnaround—not a cheap growth story—where the upside depends on bookings converting into sustained organic revenue and operating income rising comfortably above interest expense; investors should remain cautious until free cash flow visibly reduces debt and validates the cost-led recovery.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Quarterly Improvement
- •Weak Liquidity
- •High Leverage
FTRE's improving quarterly operations and positive free cash flow are encouraging, but weak liquidity, heavy leverage, and inadequate interest coverage keep the risk profile elevated.
Price Behavior
Key Price Behavior Insights:
- •Strong September rally
- •Near-term pullback
- •Breakout resistance
FTRE gained 9.6% over the last month, but after pulling back from $20.28, traders should watch $18.80–$19.00 support and a breakout above $20.28–$20.40.
Sharp rally from $17.20 after 2026-09-11 followed by profit-taking
Sentiment & News
Key News Insights:
- •EBITDA Expansion
- •Early-Phase Acquisition
- •Revenue Conversion
Fortrea's margin recovery and early-phase acquisition signal improving profitability and growth potential, though sustained revenue conversion remains the key execution risk.
The developments are cautiously positive for Fortrea, but investor confidence will depend on translating stronger bookings into revenue growth
Similar Companies in Healthcare
Other companies in the same sector with AI ratings